Letter: role of GNβ3 polymorphisms in oesophageal adenocarcinoma and gastroesophageal reflux disease

E-ISSN： 1365-2036|41|6|600-601

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.41, Iss.6, 2015-03, pp. : 600-601

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gastroesophageal Reflux Disease

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 46, Iss. 12, 1998-12 ,pp. : 1558-1565

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: proton pump inhibitor‐responsive oesophageal eosinophilia – more than just gastro‐oesophageal reflux disease. Authors' reply

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 44, Iss. 8, 2016-10 ,pp. : 912-913

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: proton pump inhibitor‐responsive oesophageal eosinophilia – more than just gastro‐oesophageal reflux disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 44, Iss. 8, 2016-10 ,pp. : 911-912

John Wiley & Sons Inc

Access to resources Recommend Favorite

Challenges in the diagnosis of gastroesophageal reflux disease in infants and children

By Vandenplas Yvan

Expert Opinion on Medical Diagnostics, Vol. 7, Iss. 3, 2013-05 ,pp. : 289-298

Informa Healthcare

Access to resources Recommend Favorite

Dangerous Liaisons? Gastroesophageal Reflux Disease and Organizing Pneumonia

Respiration, Vol. 89, Iss. 3, 2015-02 ,pp. : 192-194

Karger

Access to resources Recommend Favorite